Skelton Eliza, Guillaumier Ashleigh, Tzelepis Flora, Walsberger Scott, Paul Christine L, Dunlop Adrian J, Palazzi Kerrin, Bonevski Billie
Faculty of Health and Medicine, School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia.
Hunter Medical Research Institute, Newcastle, Australia.
Drug Alcohol Rev. 2021 Sep;40(6):998-1002. doi: 10.1111/dar.13276. Epub 2021 Mar 28.
E-cigarettes containing nicotine may potentially assist cessation in a heavily nicotine-dependent population with high relapse and tobacco-related burden. This study aims to determine alcohol and other drug (AOD) health-care provider and client awareness, use and attitudes regarding harm reduction and safety of e-cigarettes.
The study was part of a larger cluster randomised controlled trial with 32 Australian AOD services. At a post-intervention survey conducted October 2016, health-care providers were asked whether they believed e-cigarettes could help smokers quit tobacco, whether they believe e-cigarettes are safer than tobacco smoking and whether they would recommend e-cigarettes to clients who are interested in quitting smoking. At the 6-month follow-up survey conducted January 2015-March 2016, AOD clients were asked about their e-cigarette knowledge, ever use, current use, reasons for use and place of purchase.
One hundred and eighty health-care providers and 427 AOD clients responded. A minority of health-care providers agreed with the statements that e-cigarettes could help smokers quit tobacco (30%), while just under one-third (25%) agreed that e-cigarettes were safer than tobacco smoking. However, only 19% would recommend e-cigarettes. Most AOD clients (93%) reported awareness of e-cigarettes, 39% reported ever use; however, only 7% reported current use. Of those reporting ever use, 52% used a nicotine e-cigarette. The most common reasons for e-cigarette use were 'wanted to try' (72%) and 'help cut down smoking' (70%).
Both AOD health-care providers and clients are aware of e-cigarettes but are cautious in using and recommending their use.
含尼古丁的电子烟可能有助于重度尼古丁依赖人群戒烟,这类人群复吸率高且有与烟草相关的负担。本研究旨在确定酒精及其他药物(AOD)医疗服务提供者和服务对象对电子烟减害及安全性的认知、使用情况和态度。
该研究是一项针对32家澳大利亚AOD服务机构的大型整群随机对照试验的一部分。在2016年10月进行的干预后调查中,询问医疗服务提供者他们是否认为电子烟能帮助吸烟者戒烟、是否认为电子烟比吸烟更安全以及是否会向有戒烟意愿的服务对象推荐电子烟。在2015年1月至2016年3月进行的6个月随访调查中,询问AOD服务对象他们的电子烟知识、是否曾经使用、目前是否使用、使用原因及购买地点。
180名医疗服务提供者和427名AOD服务对象做出了回应。少数医疗服务提供者同意电子烟能帮助吸烟者戒烟的说法(30%),而略低于三分之一(25%)的人同意电子烟比吸烟更安全。然而,只有19%的人会推荐电子烟。大多数AOD服务对象(93%)表示知晓电子烟,39%报告曾经使用过;然而,只有7%报告目前正在使用。在报告曾经使用过的人中,52%使用的是含尼古丁的电子烟。使用电子烟最常见的原因是“想尝试一下”(72%)和“帮助减少吸烟量”(70%)。
AOD医疗服务提供者和服务对象都知晓电子烟,但在使用和推荐使用方面持谨慎态度。